2020 US Molecular Diagnostics and NAT Market: Supplier Shares and Sales Segment Forecasts
This report provides:
Five-year sales forecasts for the US Molecular Diagnostics market, including:
Sales and market shares for major suppliers of molecular diagnostics and NAT assays.
Contains 5 pages
Five-year sales forecasts for the US Molecular Diagnostics market, including:
- Infectious Diseases
- Cancer
- Forensic Testing
- Genetic Diseases
- Paternity Testing/HLA Typing, and other applications.
Sales and market shares for major suppliers of molecular diagnostics and NAT assays.
Contains 5 pages
This report provides:
Five-year sales forecasts for the US Molecular Diagnostics market, including:
Infectious Diseases
Cancer
Forensic Testing
Genetic Diseases
Paternity Testing/HLA Typing, and other applications.
Sales forecasts for HIV, Hepatitis (A, B, C), Parvovirus B19 and West Nile Virus.
Sales and market shares for major suppliers of molecular diagnostics and NAT assays.
Five-year sales forecasts for the US Molecular Diagnostics market, including:
Infectious Diseases
Cancer
Forensic Testing
Genetic Diseases
Paternity Testing/HLA Typing, and other applications.
Sales forecasts for HIV, Hepatitis (A, B, C), Parvovirus B19 and West Nile Virus.
Sales and market shares for major suppliers of molecular diagnostics and NAT assays.
LIST OF TABLES
Table 1. U.S.A.: Molecular Diagnostics Market by Major Application
Table 2. U. S.A.: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 3. U.S.A.: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 4. U.S.A.: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 5. U.S.A.: West Nile Virus Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 1. U.S.A.: Molecular Diagnostics Market by Major Application
Table 2. U. S.A.: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 3. U.S.A.: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 4. U.S.A.: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
Table 5. U.S.A.: West Nile Virus Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
More Publications
2016 Future Horizons and Growth Strategies in the US Endocrine Function Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 2,800.00
November 2015
271 pages
2020 US Endocrine Function Testing Market for 20 Assays: US, Europe, Japan-Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
US$ 3,850.00
February 2020
271 pages
2015 Strategies in the US Physician Office and Group Practice Diagnostic Testing Market
US$ 10,000.00
May 2015
970 pages
Future Horizons and Growth Strategies in the US Clinical Chemistry and Immunodiagnostics Market 2015: Supplier Shares and Country Forecasts
US$ 9,200.00
June 2015
600 pages
2020 US Immunodiagnostics Market: Supplier Shares and Sales Segment Forecasts
US$ 950.00
March 2020
35 pages